Private Equity & Securities

Gooder Foods, Inc., a KO client, recently raised $6.4 million to launch Goodles – a new, healthier mac and cheese brand. The KO team, led by partner Jennifer Rosenthal, represented Gooder Foods. Co-founded by actress Gal Gadot, Goodles is high in vegetables, protein and fiber and aims to provide a tastier,…

Superplastic, a KO client and global entertainment brand, has raised $20 million to expand its first-of-its-kind virtual ecosystem. The KO team, led by partner Jon Taylor, represented Superplastic.   Superplastic creates and manages animated celebrities with millions of dedicated followers, including Janky & Guggimon, Dayzee & Staxx, Kranky, ShüDog and more. Via its ecosystem,…

Sydnexis, Inc., a clinical stage biopharmaceutical company, has completed a $45 million Series B financing led by Visionary Ventures, Blue Stem Capital, and SC Master Fund. The KO team, led by partners Kevin Gibson and Brad Schoenfeld, represented Sydnexis. The company sees progressive myopia (nearsightedness) in children as a “significant…

Tilting Point, a leading free-to-play games publisher and KO client, recently raised $235 million in an equity financing led by General Atlantic. This funding will support the company’s progressive game publishing model, mergers and acquisitions and international growth. KO partners Jon Taylor and Charles Ciaccio along with attorneys Melissa Mellen,…

KO led its client, Qwinix Technologies, Inc., through a merger with Cloudbakers LLC in an acquisition deal with Sunstone Partners, a growth-oriented private equity firm focused on tech-enabled cloud services companies. Sunstone says the merging of these two Google ecosystem-leaders will create one of the largest Google Cloud-focused partners in…

Company formations capitalize on innovation, time and talent during downturn While it may seem counterintuitive or surprising to some, historically we’ve seen that economic downturns can be a good time to start a business. Many successful entrepreneurs know this and see several opportunities during a decline: This is a good…

Today, many have the misperception that M&A deals aren’t getting done because of the ongoing COVID-19 pandemic, or that the only deals closing are distressed deals that are unfavorable to the seller. But there’s more to the story. While we have seen a shift from a seller-favorable market to a…

KO client Nanospectra Biosciences, a medical device company that is pioneering a novel use of nanomedicine to destroy tumors without damaging adjacent healthy tissue, recently closed a $3 million Series B-1 financing with total approved capital of up to $6 million. The financing will be used for additional development and…